• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床全外显子组测序知情同意书之间的差异。

Variation among Consent Forms for Clinical Whole Exome Sequencing.

作者信息

Fowler Sara A, Saunders Carol J, Hoffman Mark A

机构信息

Department of Biomedical and Health Informatics, University of Missouri-Kansas City, Kansas City, MO, USA.

Center for Pediatric Genomic Medicine, Children's Mercy Hospital, Kansas City, MO, USA.

出版信息

J Genet Couns. 2018 Feb;27(1):104-114. doi: 10.1007/s10897-017-0127-2. Epub 2017 Jul 8.

DOI:10.1007/s10897-017-0127-2
PMID:28689263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5794809/
Abstract

The goal of this study was to explore variation among informed consent documents for clinical whole exome sequencing (WES) in order to identify the level of consistency with the recommendations from the American College of Medical Genetics and Genomics (ACMG) and the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) regarding informed consent for clinical WES. Recommendations were organized into a framework of key points for analysis. Content analysis was conducted on a sample of informed consent documents for clinical WES downloaded from 18 laboratory websites. We observed considerable variability in the content of informed consent documents among the sample of 18 laboratories. The mean Flesch-Kincaid Grade Level, a measure of readability, of the consent forms was 10.8, above the recommended 8th grade level. For each of the individual ACMG and Bioethics Commission recommendations, the frequency of inclusion ranged from 11% to 100%. For the overall list of 18 consent items, inclusion ranged from 11 to 17 items (Mean = 13.44, Mode = 14). This analysis will be useful to laboratories that wish to create informed consent documents that comply with these recommendations. The consistent use of standardized informed consent process could improve communication between clinicians and patients and increase understanding of genetic testing.

摘要

本研究的目的是探究临床全外显子组测序(WES)知情同意文件之间的差异,以确定其与美国医学遗传学与基因组学学会(ACMG)和总统生物伦理问题研究委员会(生物伦理委员会)关于临床WES知情同意的建议的一致程度。建议被整理成一个分析要点框架。对从18个实验室网站下载的临床WES知情同意文件样本进行了内容分析。我们观察到18个实验室样本的知情同意文件内容存在相当大的差异。同意书的平均弗莱什-金凯德年级水平(一种可读性指标)为10.8,高于建议的8年级水平。对于ACMG和生物伦理委员会的每项单独建议,纳入频率从11%到100%不等。对于18项同意项目的总体清单,纳入项目从11项到17项不等(平均值 = 13.44,众数 = 14)。该分析对于希望创建符合这些建议的知情同意文件的实验室将是有用的。标准化知情同意流程的一致使用可以改善临床医生与患者之间的沟通,并增加对基因检测的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7f2/5794809/9745d074e7e9/10897_2017_127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7f2/5794809/7285aa57f977/10897_2017_127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7f2/5794809/9745d074e7e9/10897_2017_127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7f2/5794809/7285aa57f977/10897_2017_127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7f2/5794809/9745d074e7e9/10897_2017_127_Fig2_HTML.jpg

相似文献

1
Variation among Consent Forms for Clinical Whole Exome Sequencing.临床全外显子组测序知情同意书之间的差异。
J Genet Couns. 2018 Feb;27(1):104-114. doi: 10.1007/s10897-017-0127-2. Epub 2017 Jul 8.
2
The readability of informed consent forms for research studies conducted in South Africa.南非开展的研究性医学临床试验知情同意书的可读性。
S Afr Med J. 2021 Feb 1;111(2):180-183. doi: 10.7196/SAMJ.2021.v111i2.14752.
3
Shortened consent forms for genome-wide sequencing: Parent and provider perspectives.全基因组测序简短知情同意书:家长和提供者的观点。
Mol Genet Genomic Med. 2020 Jul;8(7):e1254. doi: 10.1002/mgg3.1254. Epub 2020 May 8.
4
Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.了解美国基因组测序实验室次要发现报告实践的差异。
AJOB Empir Bioeth. 2018 Jan-Mar;9(1):48-57. doi: 10.1080/23294515.2017.1405095. Epub 2017 Dec 21.
5
Readability of consent forms in veterinary clinical research.兽医临床研究中知情同意书的可读性
J Vet Intern Med. 2019 Mar;33(2):350-355. doi: 10.1111/jvim.15462. Epub 2019 Feb 22.
6
Readability of informed consent forms for whole-exome and whole-genome sequencing.全外显子组和全基因组测序知情同意书的可读性。
J Community Genet. 2018 Apr;9(2):143-151. doi: 10.1007/s12687-017-0324-6. Epub 2017 Aug 31.
7
Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials.新型冠状病毒肺炎疫苗试验知情同意书的长度与可读性评估
JAMA Netw Open. 2021 Apr 1;4(4):e2110843. doi: 10.1001/jamanetworkopen.2021.10843.
8
Assessing the readability statistics of national consent forms in the UK.评估英国国家知情同意书的可读性统计数据。
Int J Clin Pract. 2010 Feb;64(3):322-9. doi: 10.1111/j.1742-1241.2009.02245.x.
9
Do informed consent documents for chiropractic clinical research studies meet readability level recommendations and contain required elements: a descriptive study.脊椎按摩疗法临床研究的知情同意文件是否符合可读性水平建议并包含所需要素:一项描述性研究。
Chiropr Man Therap. 2014 Dec 10;22(1):40. doi: 10.1186/s12998-014-0040-9. eCollection 2014.
10
Assessing readability and comprehension of informed consent materials for medical device research: A survey of informed consents from FDA's Center for Devices and Radiological Health.评估医疗器械研究知情同意书的可读性和理解度:对 FDA 设备和放射健康中心知情同意书的调查。
Contemp Clin Trials. 2019 Oct;85:105831. doi: 10.1016/j.cct.2019.105831. Epub 2019 Aug 21.

引用本文的文献

1
Analysis of informed consent forms of patients undergoing cancer genetic testing in the era of next-generation sequencing.下一代测序时代癌症基因检测患者知情同意书分析
Hered Cancer Clin Pract. 2025 Feb 21;23(1):8. doi: 10.1186/s13053-025-00309-8.
2
Assessment of the current status of real-world pharmacogenomic testing: informed consent, patient education, and related practices.真实世界药物基因组学检测现状评估:知情同意、患者教育及相关实践
Front Pharmacol. 2024 Feb 8;15:1355412. doi: 10.3389/fphar.2024.1355412. eCollection 2024.
3
Parental Access to Children's Raw Genomic Data in Canada: Legal Rights and Professional Responsibility.

本文引用的文献

1
The Limits of Informed Consent for an Overwhelmed Patient: Clinicians' Role in Protecting Patients and Preventing Overwhelm.不堪重负患者的知情同意权限制:临床医生在保护患者及防止其不堪重负方面的作用
AMA J Ethics. 2016 Sep 1;18(9):869-86. doi: 10.1001/journalofethics.2016.18.9.peer2-1609.
2
TRANSFORMING HEALTH CARE DELIVERY INTO A LEARNING HEALTH CARE SYSTEM.将医疗服务转变为学习型医疗体系。
Physician Leadersh J. 2015 Nov-Dec;2(6):12-4, 16.
3
Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice.基因检测的偶然发现:对遗传咨询实践的影响
加拿大父母获取子女原始基因组数据的法律权利与职业责任
Front Genet. 2021 Mar 31;12:535340. doi: 10.3389/fgene.2021.535340. eCollection 2021.
4
Please give me a copy of my child's raw genomic data.请给我一份我孩子的原始基因组数据。
NPJ Genom Med. 2021 Feb 17;6(1):15. doi: 10.1038/s41525-021-00175-y.
5
Shortened consent forms for genome-wide sequencing: Parent and provider perspectives.全基因组测序简短知情同意书:家长和提供者的观点。
Mol Genet Genomic Med. 2020 Jul;8(7):e1254. doi: 10.1002/mgg3.1254. Epub 2020 May 8.
6
Informed Consent in the Genomics Era.基因组学时代的知情同意
Cold Spring Harb Perspect Med. 2020 Aug 3;10(8):a036582. doi: 10.1101/cshperspect.a036582.
7
Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium.临床基因组测序同意书:来自临床测序探索性研究联盟的考虑因素。
Per Med. 2019 Jul;16(4):325-333. doi: 10.2217/pme-2018-0076. Epub 2019 Jul 17.
8
The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.临床测序证据生成研究联盟:在不同和医疗资源不足的人群中整合基因组测序。
Am J Hum Genet. 2018 Sep 6;103(3):319-327. doi: 10.1016/j.ajhg.2018.08.007.
9
Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms.临床基因组测序知情同意书中 VUS 报告、变异重新解读和再联系政策分析。
Eur J Hum Genet. 2018 Dec;26(12):1743-1751. doi: 10.1038/s41431-018-0239-7. Epub 2018 Aug 24.
Curr Genet Med Rep. 2015;3(4):166-176. doi: 10.1007/s40142-015-0075-9. Epub 2015 Aug 25.
4
The History of Patenting Genetic Material.专利遗传物质的历史。
Annu Rev Genet. 2015;49:161-82. doi: 10.1146/annurev-genet-112414-054731. Epub 2015 Oct 6.
5
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.一种用于评估基因组规模测序中偶然发现或次要发现的临床可操作性的半定量指标。
Genet Med. 2016 May;18(5):467-75. doi: 10.1038/gim.2015.104. Epub 2015 Aug 13.
6
The new world of genomic testing, families and privacy.基因组检测、家庭与隐私的新世界。
Minn Med. 2015 Jun;98(6):32-4.
7
Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.全外显子组测序作为1型发作性共济失调一家系的诊断工具
Mayo Clin Proc. 2015 Mar;90(3):366-71. doi: 10.1016/j.mayocp.2015.01.001. Epub 2015 Feb 3.
8
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.美国医学遗传学与基因组学学会政策声明:关于临床全基因组测序中次要发现的分析和报告的更新建议
Genet Med. 2015 Jan;17(1):68-9. doi: 10.1038/gim.2014.151. Epub 2014 Nov 13.
9
Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues).预见和沟通:临床、研究和直接面向消费者背景下偶然和次要发现的伦理管理(生物伦理问题总统委员会 2013 年 12 月报告)。
Am J Epidemiol. 2014 Sep 15;180(6):562-4. doi: 10.1093/aje/kwu217. Epub 2014 Aug 22.
10
Genetic counseling practice in next generation sequencing research: implications for the ethical oversight of the informed consent process.下一代测序研究中的遗传咨询实践:对知情同意过程伦理监督的启示
J Genet Couns. 2014 Aug;23(4):661-70. doi: 10.1007/s10897-014-9703-x. Epub 2014 Mar 25.